People: Akorn Inc (AKRX.O)

AKRX.O on Nasdaq

38.90USD
27 Aug 2014
Price Change (% chg)

$-0.12 (-0.31%)
Prev Close
$39.02
Open
$39.24
Day's High
$39.28
Day's Low
$38.50
Volume
1,391,142
Avg. Vol
1,100,952
52-wk High
$39.48
52-wk Low
$17.77

Search Stocks

Kapoor, John 

Brief Biography

Dr. John N. Kapoor, Ph.D. serves as Chairman of the Board of Akorn Inc. Dr. Kapoor served as interim Chief Executive Officer from March 2001 to May 2002 and as Chief Executive Officer from May 2002 to December 2002. Dr. Kapoor is the President of EJ Financial Enterprises, Inc. (a health care consulting and investment company). Dr. Kapoor is the chairman of the board of directors of Insys Therapeutics, a private drug development company focused on pain and oncology, into which NeoPharm, Inc. (previously a publicly held biopharmaceutical company) merged in October 2010. Prior to NeoPharm’s merger, Dr. Kapoor was the chairman of its board of directors.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
2,083 -- -- 2,083

Options Compensation

  Quantity Market Value
Exercisable 385,000 --
Unexercisable 125,000 --
Exercised 5,000 20,475.00
Name Fiscal Year Total

John Kapoor

2,083

Rajat Rai

1,637,450

Timothy Dick

532,500

Bruce Kutinsky

590,237

Mark Silverberg

434,823

Joseph Bonaccorsi

496,128
As Of 30 Dec 2013
Search Stocks